VI
Vivo Bio Tech Ltd (VIVOBIOT)
₹14.64
Mkt cap
₹37 Cr
P/E ratio
—
P/B
0.35
Div yield
0.00%
ROE
−2.00%
ROCE
7.29%
EPS (TTM)
—
Book value
₹42
52W range
15–21
Sector
Healthcare
Price history
Previous close
Incorporated in 1987, Vivo Bio Tech Ltd is engaged in service of CRO offering Drug Development & Discovery Services to Pharmaceutical & Biotech Companies [1]
NSE VIVOBIOTBSE 511509
Health check
Cautious
ProfitabilityWeak
GrowthModerate
TechnicalsNeutral
52-week range
−30.09% from high₹15
₹15+0.27% from low₹21
Current
₹14.64
Prev close
₹15.30
Day
−4.31%
Price performance
1D
−4.31%
1W
−9.96%
1M
−21.71%
3M
—
6M
—
1Y
—
YTD
−25.61%
Financials
Revenue, profit & margin
| Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Trend | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 11.58 | 9.26 | 12.85 | 11.76 | 10.13 | 12.04 | 12.21 | 12.29 | 12.51 | 13.11 | 13.51 | 14.20 | 14.28 | |
| Expenses | 7.09 | 4.40 | 6.48 | 6.39 | 5.77 | 6.45 | 6.67 | 7.27 | 7.03 | 7.69 | 8.02 | 9.75 | 9.23 | |
| Operating Profit | 4.49 | 4.86 | 6.37 | 5.37 | 4.36 | 5.59 | 5.54 | 5.02 | 5.48 | 5.42 | 5.49 | 4.45 | 5.05 | |
| OPM % | 38.77% | 52.48% | 49.57% | 45.66% | 43.04% | 46.43% | 45.37% | 40.85% | 43.80% | 41.34% | 40.64% | 31.34% | 35.36% | |
| Other Income | 0.00 | 0.00 | 0.03 | 0.01 | 0.01 | 4.63 | 0.01 | 0.15 | 0.14 | 0.13 | 0.14 | 0.03 | 0.06 | |
| Interest | 1.95 | 2.09 | 2.22 | 1.52 | 1.92 | 2.06 | 1.84 | 1.68 | 1.50 | 1.47 | 1.40 | 1.48 | 1.24 | |
| Depreciation | 2.29 | 2.30 | 2.28 | 2.43 | 2.23 | 2.29 | 2.25 | 2.25 | 2.64 | 2.57 | 2.66 | 2.75 | 3.53 | |
| Profit before tax | 0.25 | 0.47 | 1.90 | 1.43 | 0.22 | 5.87 | 1.46 | 1.24 | 1.48 | 1.51 | 1.57 | 0.25 | 0.34 | |
| Tax % | 44.00% | 29.79% | 31.05% | 48.95% | 27.27% | 10.73% | 43.84% | 14.52% | 9.46% | 42.38% | 20.38% | 2,164.00% | 44.12% | |
| Net Profit | 0.14 | 0.33 | 1.32 | 0.74 | 0.17 | 5.23 | 0.82 | 1.06 | 1.34 | 0.87 | 1.25 | -5.16 | 0.19 | |
| EPS in Rs | 0.09 | 0.22 | 0.89 | 0.50 | 0.11 | 3.51 | 0.51 | 0.62 | 0.67 | 0.39 | 0.57 | -2.33 | 0.09 | |
| Raw PDF |
Earnings
Results dates & reactionsNo upcoming results date on calendar.
Fresh quarters land in the Financials table above, tagged NSE until screener catches up.
No reaction history yet.
No quarterly filings ingested yet.
Corporate actions
Last 6 monthsNo recent corporate actions
Dividends, splits, and bonuses in the last six months show up here.
Shareholding
as of Jun 202630.62%Promoter
Promoters30.62%4.81
Public69.39%4.81
Ownership trend
Peers
6 companies| Name | CMP | P/E | Mkt Cap | Div Yld | NP Qtr | Qtr Profit Var | Sales Qtr | Qtr Sales Var | ROCE |
|---|---|---|---|---|---|---|---|---|---|
| Anthem Bioscienc | ₹928.50 | 88.16 | 52,306 | 0.22% | 120 | −11.67% | 418 | −22.58% | 30.37% |
| Advanced Enzyme | ₹287.80 | 20.45 | 3,223 | 1.86% | 39 | −7.11% | 190 | +2.09% | 13.96% |
| CCME Global | ₹36.45 | — | 165 | 0.00% | 0 | −116.67% | 0 | — | −2.92% |
| Vivo Bio Tech | ₹16.77 | — | 37 | 0.00% | 0 | −85.82% | 14 | +14.15% | 7.29% |
| Shree Ganesh Bio | ₹0.48 | — | 19 | 0.00% | −1 | −272.73% | 1 | +3.62% | 1.31% |
| Genomic Valley | ₹28.73 | 878.00 | 9 | 0.00% | 0 | −50.00% | 0 | −55.56% | 1.02% |
| Median: 3 Co. | ₹287.80 | 54.30 | 3,223 | 0.22% | 39 | −11.67% | 190 | −10.24% | 13.96% |
Filings
Annual reports15
Credit ratings6
Announcements5
Re-Lodgement Of Transfer Requests Of Physical Shares. 10 Sep - Reported NIL re-lodgement requests for physical share transfers in August 2026.Web Link Intimation 9 Sep - Annual report sent; AGM scheduled for 30 September 2026 at 3:00 PM via VC/OAVM.Announcement under Regulation 30 (LODR)-Newspaper Publication 9 SepReg. 34 (1) Annual Report. 8 Sep - Annual Report and 39th AGM notice for FY2025-26; AGM on September 30, 2026 via VC/OAVM.39Th Annual General Meeting Notice. 8 Sep - 39th AGM on September 30, 2026 via VC/OAVM; approve financials and reappoint two whole-time directors.